Peramivir trihydrate is an antiviral medication belonging to the neuraminidase inhibitor class, used mainly for the treatment of acute influenza A and B infections. It works by inhibiting viral neuraminidase, thereby preventing the release and spread of new viral particles in the body. Its therapeutic use is listed as antivirals. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Rapivab (TN) and Peramivir hydrate. Its PubChem CID is 11954371.
Peramivir trihydrate
| CAS No | 1041434-82-5 |
|---|---|
| Molecular Formula | C15H34N4O7 |
| Molecular Weight | 382.45 g/mol |
| Synonyms | (1S,2S,3S,4R)-3-[(1S)-1-acetamido-2-ethylbutyl]-4-(diaminomethylideneamino)-2-hydroxycyclopentane-1-carboxylic acid;trihydrate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Peramivir trihydrate is an antiviral medication belonging to the neuraminidase inhibitor class, used mainly for the treatment of acute influenza A and B infections.
The listed CAS number is 1041434-82-5.
The listed molecular formula is C15H34N4O7.
The listed molecular weight is 382.45 g/mol.
(1S,2S,3S,4R)-3-[(1S)-1-acetamido-2-ethylbutyl]-4-(diaminomethylideneamino)-2-hydroxycyclopentane-1-carboxylic acid;trihydrate.
The source lists Rapivab (TN) and Peramivir hydrate.